Crossmark

Development and validation of a nomogram model based on inflammatory markers and cardiac parameters: predicting the risk of recurrence in patients with atrial fibrillation after radiofrequency catheter ablation

Crossref DOI link: https://doi.org/10.1186/s12872-026-05704-0

Published Online: 2026-03-13

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Meng, Jiaming

Zhang, Tiantian

Zhu, Liubing

Li, Sutong

Zhang, Linli

Miao, Liu

Liu, Yanli
Funding

Funding for this research was provided by:

Innovative Research Group Project of the National Natural Science Foundation of China (82560087)

Liuzhou Science and Technology Plan (2022CAC0202)

Self-funded Western Medicine Research Project by Guangxi Health Commission (Z-B20231324)
License Information

Text and Data Mining valid from 2026-03-13

Version of Record valid from 2026-04-21
More Information

Article History

Received: 30 November 2025

Accepted: 3 March 2026

First Online: 13 March 2026

Declarations

:

: The study protocol was approved by the Ethics Committee of Liuzhou People’s Hospital (Ethics approval number: 2025SL248-ZGC), and the study complied with the ethical guidelines outlined in the Declaration of Helsinki. As this study is a retrospective case study, it has been approved by the Ethics Committee of Liuzhou People’s Hospital and is exempt from obtaining informed consent. The study only involves extracting data from subject records, and patient data is anonymous or confidential.

: No.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below